AHA Sees No Link Between Gum Disease and Heart Disease
Published Online: Wednesday, December 19, 2012
This podcast, from the University of Kansas Hospital, discusses a statement from the American Heart Association rejecting the longstanding belief that untreated gum disease can lead to heart disease or stroke.
The FDA’s Cardiovascular and Renal Drugs Advisory Committee has recommended the approval of edoxaban (Savaysa) for treating patients with nonvalvular atrial fibrillation, a type of arrhythmia that can potentially cause a stroke.
Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.